It could be speculated that the delay in cancer progression by mitochondrial stress signaling may extend beyond the mutant p53 state, but based on these preliminary findings, more studies are necessary to determine the cancer preventive efficacy of metformin in other conditions. The gene discussed is TP53; the disease is cancer.